XML 13 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Employee Severance, Litigation, and Other
6 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Employee Severance, Litigation, and Other Employee Severance, Litigation, and Other

The following illustrates the charges incurred by the Company relating to Employee Severance, Litigation, and Other for the periods indicated:
 
 
Three months ended
March 31,
 
Six months ended
March 31,
(in thousands)
 
2020
 
2019
 
2020
 
2019
Employee severance
 
$
25,006

 
$
14,021

 
$
25,845

 
$
18,806

Litigation and opioid-related costs
 
30,815

 
13,822

 
55,481

 
28,361

Acquisition-related deal and integration costs
 
348

 
11,456

 
803

 
22,045

Business transformation efforts
 
9,034

 
9,873

 
17,494

 
16,852

Other restructuring initiatives
 
2,529

 
6,217

 
7,418

 
9,997

    Total employee severance, litigation, and other
 
$
67,732

 
$
55,389

 
$
107,041

 
$
96,061



Employee severance in the three and six months ended March 31, 2020 included costs primarily related to position eliminations resulting from the Company's decision to permanently exit the PharMEDium compounding business. Employee severance in the three and six months ended March 31, 2019 included costs primarily related to PharMEDium restructuring activities, position eliminations resulting from the Company's business transformation efforts and the integration of H.D. Smith, and restructuring activities related to its consulting business.

Litigation and opioid-related costs in the three and six months ended March 31, 2020 and 2019 related to legal fees in connection with opioid lawsuits and investigations.

Acquisition-related deal and integration costs in the three and six months ended March 31, 2019 primarily related to the integration of H.D. Smith. Integration costs primarily included costs to transition servicing legacy H.D. Smith customers to existing Company distribution facilities and operating systems.

Business transformation efforts in the three and six months ended March 31, 2020 and 2019 primarily related to costs associated with reorganizing the Company to further align the organization to its customers' needs. The majority of these costs related to services provided by third-party consultants, including certain technology initiatives.